These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2091237)

  • 1. Toxic mechanisms of the heart: a review.
    Combs AB; Acosta D
    Toxicol Pathol; 1990; 18(4 Pt 1):583-96. PubMed ID: 2091237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
    Phillips K; Luk A; Soor GS; Abraham JR; Leong S; Butany J
    Am J Cardiovasc Drugs; 2009; 9(3):177-96. PubMed ID: 19463023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alcohol and myocarditis].
    Wilke A; Kaiser A; Ferency I; Maisch B
    Herz; 1996 Aug; 21(4):248-57. PubMed ID: 8805005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology of ipecac: a review.
    Manno BR; Manno JE
    Clin Toxicol; 1977; 10(2):221-42. PubMed ID: 15766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
    Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
    Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of alcohol on the heart.
    Patel VB; Why HJ; Richardson PJ; Preedy VR
    Adverse Drug React Toxicol Rev; 1997 Mar; 16(1):15-43. PubMed ID: 9192055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.
    Tokarska-Schlattner M; Zaugg M; Zuppinger C; Wallimann T; Schlattner U
    J Mol Cell Cardiol; 2006 Sep; 41(3):389-405. PubMed ID: 16879835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1.
    Olson LE; Bedja D; Alvey SJ; Cardounel AJ; Gabrielson KL; Reeves RH
    Cancer Res; 2003 Oct; 63(20):6602-6. PubMed ID: 14583452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of toxic cardiomyopathy.
    Hantson P
    Clin Toxicol (Phila); 2019 Jan; 57(1):1-9. PubMed ID: 30260248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac effects of cocaine: a review.
    Gradman AH
    Yale J Biol Med; 1988; 61(2):137-47. PubMed ID: 3043926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and prevention of doxorubicin cardiomyopathy.
    Ferrans VJ; Clark JR; Zhang J; Yu ZX; Herman EH
    Tsitologiia; 1997; 39(10):928-37. PubMed ID: 9505340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.
    Minotti G; Ronchi R; Salvatorelli E; Menna P; Cairo G
    Cancer Res; 2001 Dec; 61(23):8422-8. PubMed ID: 11731422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity.
    Xin YF; Zhou GL; Shen M; Chen YX; Liu SP; Chen GC; Chen H; You ZQ; Xuan YX
    Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):421-6. PubMed ID: 17971065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and diagnosis of cancer drug induced cardiomyopathy.
    Zuppinger C; Timolati F; Suter TM
    Cardiovasc Toxicol; 2007; 7(2):61-6. PubMed ID: 17652805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anthracyclines and the heart].
    Mazzarello GP; Morra L
    Recenti Prog Med; 1998 Sep; 89(9):459-64. PubMed ID: 9796378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin-induced oxidative mitochondrial cardiotoxicity.
    Berthiaume JM; Wallace KB
    Cell Biol Toxicol; 2007 Jan; 23(1):15-25. PubMed ID: 17009097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac toxicity in cancer therapy].
    Łacko A; Włodarska I; Zymliński R; Mazur G; Wróbel T; Gisterek I
    Pol Merkur Lekarski; 2002 Jul; 13(73):79-85. PubMed ID: 12362515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.